OpenTrons
Opentrons Labworks provides open-source liquid handling robots for flexible and user-friendly lab automation in biotechnology and clinical research.
Secondary Market Price
How OpenTrons Measures Up
To help you manage your OpenTrons equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of OpenTrons's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future OpenTrons Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for OpenTrons's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Opentrons Labworks Inc. develops and supplies open-source liquid handling robots designed to make laboratory automation more accessible. The company currently operates through two main business units: Opentrons Robotics, which provides flexible automation systems for life science labs, and Neochromosome, which offers genome-scale cell engineering solutions. Its products are used in academic, biopharma, and clinical research labs in over 40 countries for applications such as PCR setup, nucleic acid extraction, and protein purification. Founded in 2014, the company has since expanded its product line, established an affiliate called the Pandemic Response Lab, and secured $200 million in a Series C funding round in late 2021.
The company is currently focused on integrating artificial intelligence tooling into its lab automation platforms to help researchers design protocols and verify experiments in real time. This includes the development of vision-language-action systems intended to manage more complex workflows. Recent announcements highlight this direction, with Opentrons participating in industry events like the Festival of Genomics to discuss automated genomics workflows. The company also hosts hands-on workshops, such as a collaboration in Toulouse with Promega Corporation, to demonstrate how to implement molecular biology and cell-based assays on its Opentrons Flex robot.
- SoftBank Vision Fund 2
- Khosla Ventures
- Sands Capital
- Lerer Hippeau Ventures
- SOSV
- Y Combinator
- Co-Founder, Will Canine
- Co-Founder, Chiu Chau
- Co-Founder, Nicholas Wagner
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is OpenTrons worth joining?
Deciding whether to join a startup like OpenTrons involves evaluating its potential growth against your personal financial goals. A platform like Prospect can help you model the potential value of your equity compensation to make a more informed career decision.
What should I do with my OpenTrons stock?
Managing your OpenTrons stock requires a personalized strategy based on your financial situation, tax implications, and the company's performance. Prospect offers customized equity strategies to help you maximize the after-tax value of your shares.
Can you sell OpenTrons stock?
As OpenTrons is a private company, selling stock is typically restricted to specific events like tender offers, secondary sales, or an IPO. Prospect provides tools for tender offers to help you decide how much to sell and which shares are the most tax-optimal.
How can I find the value of my OpenTrons stock?
The value of private stock is not public and is based on factors like the latest 409A valuation and private market data. Prospect uses proprietary predictive models, trained on data used by top VCs, to help you forecast the future value of your shares.
What is OpenTrons's equity worth?
The total worth of OpenTrons's equity is based on its private valuation, which changes with funding rounds and company performance. To understand what your specific stake could be worth, you can use Prospect's platform to project a range of outcomes for your equity.
What is OpenTrons's stock ticker symbol?
OpenTrons is a private company and does not have a stock ticker symbol, as it is not traded on a public stock exchange. Ticker symbols are assigned only when a company undergoes an Initial Public Offering (IPO).
Can I buy or sell OpenTrons stock?
Buying stock in a private company like OpenTrons is typically limited to accredited investors, while selling is restricted for employees until a liquidity event. Prospect is designed for employees to manage the equity they already own, not for external investors to purchase shares.
What is the criteria to buy or invest in OpenTrons stock?
Investing in a private company like OpenTrons is generally reserved for venture capital firms and accredited investors who meet specific SEC income or net worth requirements. Prospect focuses on helping employees manage their equity compensation, rather than assisting external investors with purchasing stock.
